Alembic Pharmaceuticals Limited Market Cap ($1.93 Billion)
Market Cap & Net Worth: Alembic Pharmaceuticals Limited (APLLTD)
Alembic Pharmaceuticals Limited market cap. Alembic Pharmaceuticals Limited (NSE:APLLTD) has a market capitalization of $1.93 Billion (Rs178.22 Billion) as of November 5, 2026. Listed on the NSE stock exchange, this India-based company holds position #6092 globally and #276 in its home market, demonstrating a 18.23% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alembic Pharmaceuticals Limited's stock price Rs906.70 by its total outstanding shares 196563124 (196.56 Million). Also see APLLTD cash flow conversion for how efficiently the company converts equity into cash flow.
Alembic Pharmaceuticals Limited Market Cap History (2015–2026)
Alembic Pharmaceuticals Limited market cap history from 2015 to 2026. Data shows growth from $1.35 Billion to $1.93 Billion (2.96% CAGR). Check APLLTD share price today for real-time trading data and today's change.
Index Memberships
Alembic Pharmaceuticals Limited is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$3.06 Trillion | 0.06% | #244 of 500 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.11 Trillion | 0.17% | #157 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.14 Trillion | 0.06% | #240 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$395.04 Billion | 0.49% | #63 of 250 |
Weight: Alembic Pharmaceuticals Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Alembic Pharmaceuticals Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alembic Pharmaceuticals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Alembic Pharmaceuticals Limited (APLLTD) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.03x
Alembic Pharmaceuticals Limited's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.31x
Alembic Pharmaceuticals Limited's market cap is 0.31 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.16 Billion | $31.23 Billion | $7.20 Billion | 0.04x | 0.16x |
| 2017 | $1.05 Billion | $31.05 Billion | $4.03 Billion | 0.03x | 0.26x |
| 2018 | $1.19 Billion | $31.30 Billion | $4.13 Billion | 0.04x | 0.29x |
| 2019 | $1.15 Billion | $39.35 Billion | $5.84 Billion | 0.03x | 0.20x |
| 2020 | $2.09 Billion | $46.06 Billion | $8.29 Billion | 0.05x | 0.25x |
| 2021 | $1.64 Billion | $53.93 Billion | $11.46 Billion | 0.03x | 0.14x |
| 2022 | $1.19 Billion | $53.06 Billion | $5.21 Billion | 0.02x | 0.23x |
| 2023 | $1.60 Billion | $56.53 Billion | $3.42 Billion | 0.03x | 0.47x |
| 2024 | $2.27 Billion | $62.29 Billion | $6.16 Billion | 0.04x | 0.37x |
| 2025 | $1.80 Billion | $66.72 Billion | $5.83 Billion | 0.03x | 0.31x |
Competitor Companies of APLLTD by Market Capitalization
Companies near Alembic Pharmaceuticals Limited in the global market cap rankings as of November 5, 2026. Also see Alembic Pharmaceuticals Limited balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Alembic Pharmaceuticals Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Alembic Pharmaceuticals Limited (2015–2026)
Market capitalization of Alembic Pharmaceuticals Limited from 2015 to today. Between 2015 and today, Alembic Pharmaceuticals Limited's market cap moved from $1.35 Billion to $ 1.93 Billion, with a yearly change of 2.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.93 Billion | +7.16% |
| 2025 | Rs1.80 Billion | -20.64% |
| 2024 | Rs2.27 Billion | +41.99% |
| 2023 | Rs1.60 Billion | +34.02% |
| 2022 | Rs1.19 Billion | -27.46% |
| 2021 | Rs1.64 Billion | -21.29% |
| 2020 | Rs2.09 Billion | +81.90% |
| 2019 | Rs1.15 Billion | -3.73% |
| 2018 | Rs1.19 Billion | +13.90% |
| 2017 | Rs1.05 Billion | -10.14% |
| 2016 | Rs1.16 Billion | -13.91% |
| 2015 | Rs1.35 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Alembic Pharmaceuticals Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.93 Billion USD |
| MoneyControl | $1.93 Billion USD |
| MarketWatch | $1.93 Billion USD |
| marketcap.company | $1.93 Billion USD |
| Reuters | $1.93 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal healt… Read more